Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
暂无分享,去创建一个
P. Peng | Xian-xiang Chen | Qibin Liu | X. Fang | X. Dai | Xiaoyu Liu | Feng Xu
[1] Guocan Yu,et al. Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis , 2019, PloS one.
[2] Hairong Huang,et al. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. , 2019, The Journal of infection.
[3] F. Cobelens,et al. Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear–Negative Drug-Resistant Tuberculosis, China , 2019, Emerging infectious diseases.
[4] Michael L Wilson,et al. Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria , 2018, Clinical Microbiology Reviews.
[5] H. Schünemann,et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update , 2017, European Respiratory Journal.